- Jun 24, 2022
Study shows that genomic tumor profiling of pediatric tumors can enhance clinical care
Results of a study of molecular tumor profiling in young patients revealed a high rate of genetic alterations with potential for...
- Jun 23, 2022
Pushing T cells down "memory lane" may improve cancer therapy
Scientists at St. Jude Children's Research Hospital identified proteins that help decide T cell fate and used the finding to improve...
- Jun 20, 2022
Previous Cancer Not Seen to Raise Thyroid Surgery Risks for Children
Children successfully treated for a cancer who undergo thyroid surgery for a secondary thyroid disease have a similar risk of surgical ...
- Jun 16, 2022
Bortezomib extends survival of children with newly diagnosed T-cell lymphoblastic lymphoma
The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell ...
- Jun 14, 2022
A drug and a DNA variant increase heart disease risk in cancer survivors
Scientists from St. Jude Children's Research Hospital have identified a genetic variant associated with substantially increased risk of...
- Jun 13, 2022
Researchers Identify RAD21 Variants in Pediatric Lymphoblastic Leukemia or Lymphoma
A recent study involving children with hematologic malignancies has suggested that mutations in a portion of a cohesin gene known as...
- Jun 10, 2022
Adult survivors of childhood cancer often undertreated for cardiovascular risk factors
Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more...
- Jun 9, 2022
Dabrafenib + Trametinib Improve Overall Response Rates in Pediatric Patients with Low-Grade Gliomas
The combination of two targeted therapies, the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib, significantly increased the...